Table 1 Baseline characteristics of PDD patients
AF – free (N = 9136) | Incident AF (N = 455) | P-value | ||
|---|---|---|---|---|
Age (years), mean ± SD | 66 ± 12 | 66 ± 12 | 70 ± 11 | < 0.001 |
Male, n (%) | 3935 (41.0) | 3714 (40.7) | 221 (48.6) | 0.001 |
Mortality, n (%) | 996 (10.4) | 893 (9.8) | 103 (22.6) | < 0.001 |
Race/Ethnicity, n (%) | < 0.001 | |||
White | 1278 (13.3) | 1176 (12.9) | 102 (22.4) | |
Black | 3393 (35.4) | 3232 (35.4) | 161 (35.4) | |
Hispanics | 3384 (34.2) | 3146 (34.4) | 138 (30.3) | |
Others | 1636 (17.1) | 1582 (17.3) | 54 (11.9) | |
SES, mean ± SD | −3.15 ± 2.8 | −3.15 2.8 | −3.01 ± 2.9 | 0.468 |
BMI (kg/m2), median (IQR) | 28.3 (24.7–32.6) | 28.3 (24.7–32.5) | 28.3 (24.3–32.6) | 0.856* |
Comorbidities, n (%) | ||||
HTN | 7277 (75.9) | 6895 (75.5) | 382 (84.0) | < 0.001 |
MI | 822 (8.6) | 774 (8.5) | 48 (10.6) | 0.122 |
PAD | 1250 (13.0) | 1147 (12.6) | 103 (22.6) | < 0.001 |
Stroke | 1833 (19.6) | 1770 (19.4) | 113 (24.8) | < 0.001 |
DM | 3416 (35.6) | 3222 (35.3) | 306 (42.6) | 0.001 |
COPD | 2519 (26.3) | 2385 (26.1) | 134 (29.4) | 0.114 |
CKD | 1798 (18.8) | 1686 (18.5) | 112 (24.6) | 0.001 |
Malignancy | 1428 (14.9) | 1341 (14.7) | 87 (19.1) | < 0.001 |
Obesity | 3077 (38.7) | 2933 (38.7) | 144 (38.7) | 1.000 |
Medications, n (%) | ||||
ACEI/ARB | 2324 (24.2) | 2203 (24.1) | 121 (26.6) | 0.228 |
Beta-Blocker | 1796 (18.7) | 1699 (18.6) | 97 (21.3) | 0.146 |
Calcium Channel Blocker | 1922 (20.0) | 1828 (20.0) | 94 (20.7) | 0.735 |
Diuretics | 2098 (21.9) | 2001 (21.9) | 97 (21.3) | 0.769 |
Lifestyle risk factors, n (%) | ||||
Alcohol use disorder | 485 (5.1) | 467 (5.1) | 18 (4.0) | 0.272 |
Active smoking | 2267 (23.6) | 2165 (23.7) | 102 (22.4) | 0.531 |